Cite
APA Citation
Cohen, N. A., Plevris, N., Kopylov, U., Grinman, A., Ungar, B., Yanai, H., Leibovitzh, H., Isakov, N. F., Hirsch, A., Ritter, E., Ron, Y., Shitrit, A. B., Goldin, E., Dotan, I., Horin, S. B., Lees, C. W., & Maharshak, N. (2020). vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study. United European Gastroenterology journal, 8(9), 1076–1085. http://access.bl.uk/ark:/81055/vdc_100124363229.0x000010